3D Cell Culture Industry

The global 3D cell culture market was valued at USD 1.57 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.22% from 2024 to 2030. This growth is primarily driven by rising efforts to develop alternatives to animal-based testing, supported by increasing availability of funding programs for research. Furthermore, the biopharmaceutical industry’s continued emphasis on research and development (R&D) activities for drug discovery and development, along with the growing adoption of 3D cell cultures in cancer research, are expected to contribute significantly to market expansion. Traditionally, animal models have been widely used in cellular-based studies for understanding disease mechanisms; however, these models have limitations, such as differences in species-specific responses and lack of accurate outcomes. To address these challenges, various government organizations are promoting alternative methods for drug development, enhancing the appeal of 3D cell cultures.

The COVID-19 pandemic has had a considerable impact on the 3D cell culture market. The outbreak offered researchers the chance to study the novel virus and develop therapeutic and diagnostic solutions. Many leading pharmaceutical and biotechnology companies have increased their R&D efforts to create innovative vaccines, therapies, and diagnostic kits, thereby driving up demand for cell culture tools. The pandemic also heightened the need for new cell-based models, organoids, and high-throughput screening platforms to support research and drug discovery initiatives. Additionally, the urgency to develop vaccines and treatments for COVID-19 led to a surge in demand for bioreactors and culture systems, which are critical in vaccine production and drug testing. Consequently, the pandemic not only accelerated innovation in the 3D cell culture market but also underscored the importance of advanced cell culture technologies in addressing global health challenges.

Gather more insights about the market drivers, restrains and growth of the 3D Cell Culture Market

Application Insights

• The market is segmented based on application into several key areas: cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others. Among these segments, the stem cell research & tissue engineering segment held a dominant position in 2023, contributing significantly to the overall market share.
• The growth of this segment can be primarily attributed to the increasing demand for biopharmaceuticals, particularly due to the effectiveness of treatments such as cell and gene therapy. Additionally, there has been a noticeable upswing in innovation within this field, leading to a greater number of approvals for new therapies, which has further stimulated market growth.
• Projections indicate that the S. Food and Drug Administration (FDA) is expected to approve approximately 10 to 20 cell and gene therapy products annually by 2025, driven by current clinical success rates and an expanding product pipeline. This anticipated approval rate underscores the growing confidence in these innovative therapies.
• Furthermore, advancements in technology, along with supportive government legislation and increased funding for stem cell research, have facilitated the adoption of 3D culture models. For example, in March 2023, the National Institute of Health awarded USD 2.5 million in funding to a research team at Purdue University for their work in stem cell research. This financial support aims to foster investigations into novel therapeutic approaches utilizing stem cells, which hold tremendous potential for addressing various life-threatening disorders.
• The cancer research segment is projected to experience the fastest compound annual growth rate (CAGR) throughout the forecast period. This growth is largely driven by the rising prevalence of cancer, coupled with the advantages that 3D culture models provide in cancer research.
• Notably, the benefits of 3D media include their ability to alter cell proliferation and morphology, capture phenotypic heterogeneity, and offer flexibility in experimental setups. These advantages are expected to play a crucial role in supporting the expansion of the cancer research segment, as researchers seek more effective ways to study cancer biology and develop new treatment strategies.

Order a free sample PDF of the 3D Cell Culture Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com/

Follow Us: LinkedIn | Twitter